Publikationen

2008

Cathomas R.
Systemische Therapie beim Prostatakarzinom. Schweizerische Zeitschrift für Onkologie, 1/2008: S2-7.

2007

Marc Salzberg, Beat Thürlimann, Ursula Hasler, Geoffrey Delmore, Albert von Rohr, Annatina Thürlimann, Thomas Ruhstaller, Shanna Stopatschinskaja, Roger von Moos
Pegylated Liposomal Doxorubicin (Caelyx®) in Metastatic Breast Cancer: A Communitiy-Based Observation Study. Oncology. 2007 Dec 17;72(3-4):147-151

Brodmann S, Klaas EG, Cathomas R, Girardi V, von Moos R
Severe hyponatremia in a patient with mantle cell lymphoma treated with bortezomib: a case report and review of the literature. Onkologie. 2007 Dec;30(12):651-4

Cathomas R, Goldhirsch A, von Moos R
Drug-induced immune thrombocytopenia. N Engl J Med. 2007 Nov 1;357(18):1870-1

Ruhstaller T, Thuerlimann B, Koeberle D, von Moos R
Is surgery still part of local therapy in patients with locally advanced esophageal carcinoma ? J Clin Oncol. 2007 Sep 1;25(25):4025-6

Ribi K, Bernhard J, Rufibach K, Thürlimann B, von Moos R, Ruhstaller T, Glaus A, Böhme C
Endocrine symptom assessment in women with breast cancer: what a simple "yes" means. Support Care Cancer. 2007 May 26.

Inauen R, Cathomas R, Boehm T, Koeberle D, Pestalozzi BC, Gillessen S, von Moos R
Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure. Oncology. 2007 Dec 21;72(3-4):209-210

Cathomas R
Onkologie für den Grundversorger - Stand 2007. Schweiz Rundschau Med Prax 2007;96:1989-1995.

Brodmann S, Klaas Gyr E, Cathomas R, Girardi V, von Moos R
Severe Hyponatremia in a patient with mantle cell lymphoma treated with bortezomib: a case report and review of the literature. Onkologie 2007;30:651-654.

Burmeister T, Schwartz S, Taubald A, Jost E, Lipp T, Schneller F, Diedrich H, Thomssen H, Mey UJ, Eucker J, Rieder H, Gökbuget N, Hoelzer D, Thiel E
Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica. 2007 Dec;92(12):1699-702

Gorschlüter M, Glasmacher A, Sarazin S, Hackbarth F, Hoebert E, Orlopp K, Schmidt-Wolf IG, Mey UJ
CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: a retrospective study. Leuk Lymphoma. 2007 Mar;48(3):506-12

Herold M, Haas A, Srock S, Neser S, Al-Ali KH, Neubauer A, Dölken G, Naumann R, Knauf W, Freund M, Rohrberg R, Höffken K, Franke A, Ittel T, Kettner E, Haak U, Mey UJ, Klinkenstein C, Assmann M, von Grünhagen U
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study. J Clin Oncol. 2007 May 20;25(15):1986-92

Mey UJ, Maier A, Schmidt-Wolf IG, Ziske C, Forstbauer H, Banat GA, Reber M, Strehl JW, Gorschlueter M
Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma. Support Care Cancer. 2007 Jul;15(7):877-84

Mey UJ, Jha V, Strehl JW, Gorschlueter M, Rabe C, Hoebert E, Popp H, Schmidt-Wolf IG
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma. GMS Ger Med Sci 2007; 5:Doc02 (20070619)

R. von Moos und U. Hasler-Strub
Erythropoietin bei onkologischen Patienten - Segen oder Fluch? Leading Opinions Hämatologie & Onkologie. 2007(4):30-3

Fehr M, Lehmann T, Kuhn M
Chylothorax beim Staubsaugen. Schweiz Med Forum 2007; 7:630-2

Publikationen 2006

Publikationen 2005

Publikationen 2004

Publikationen 2003

Publikationen 2002

Publikationen 2000 und älter